Carol Routledge
Director Técnico/Científico/I+D en SMALL PHARMA INC. .
Origen de la red de primer grado Carol Routledge.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
18
| Public Company | Pharmaceuticals: Major | 18 |
| Public Company | Drugstore Chains | 15 | |
UK DRI Ltd.
 UK DRI Ltd. BiotechnologyHealth Technology UK DRI Ltd. is a national institute that specializes in biomedical, care, and translational dementia research. The joint venture company is based in London, UK. The British company breaks new ground by bringing together world-leading expertise in these fields.
10
| Joint Venture | Biotechnology | 10 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Carol Routledge a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree Graduate Degree Masters Business Admin Graduate Degree Corporate Officer/Principal | |
Small Pharma Ltd.
 Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded by Peter Rands in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Founder Director/Board Member Chief Operating Officer | |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| FERONIA INC. | Agricultural Commodities/Milling | Corporate Secretary Director of Finance/CFO | |
| Hunterhex AB | Director/Board Member Director/Board Member | ||
Maida Vale Capital AB
 Maida Vale Capital AB Investment Banks/BrokersFinance Maida Vale Capital AB is a private company based in Saltsjo-Boo, Sweden. The CEO of the Swedish company is Oliver Aleksov. | Investment Banks/Brokers | Director/Board Member Chairman | |
MIVAC Development AB
 MIVAC Development AB BiotechnologyHealth Technology MIVAC Development AB develops treatment of autoimmune diseases and mucosal vaccine. The company was founded in 2008 and is headquartered in Goteborg, Sweden. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| VIVESTO AB | Pharmaceuticals: Generic | Chief Executive Officer Director of Finance/CFO | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree | |
| TOLERANZIA AB | Biotechnology | Director/Board Member Director of Finance/CFO | |
| ALBIREO PHARMA, INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
Albireo Ltd.
 Albireo Ltd. Pharmaceuticals: MajorHealth Technology Albireo Ltd. develops therapies that address medical needs in the gastrointestinal and liver disease area. It is a biotechnology company that develops therapies that address unmet medical needs in the gastrointestinal area and liver disease area. The firm's programs include Cholestatic Liver Diseases; Bile Acid Mal-absorption; Type 2 Diabetes Mellitus; Atopic Dermatitis and Psoriasis; and Post-Operative Adhesions. The company was founded by Jan Peter Mattsson in February 2008 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Albireo AB
 Albireo AB Pharmaceuticals: MajorHealth Technology Albireo AB operates as a biopharmaceutical company, which focuses on the development and potential commercialization of novel bile acid modulators. It helps treat orphan pediatric liver diseases and gastrointestinal disorders where the improper flow or absorption of bile causes serious medical conditions for which there is high unmet need. The company was founded by Per-Göran Gillberg and Jan Mattsson and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Major | Founder General Counsel | |
| BAYLIN TECHNOLOGIES INC. | Specialty Telecommunications | Director of Finance/CFO Corporate Secretary | |
| Order of Pharmacists of Quebec | Corporate Officer/Principal | ||
Merck Canada, Inc.
 Merck Canada, Inc. Drugstore ChainsRetail Trade Part of Merck & Co., Inc., Merck Canada, Inc. is a Canadian biopharmaceutical company that has been inventing medicines and vaccines for over 130 years. The company is based in Kirkland, Canada and is committed to increasing access to healthcare through policies, programs, and partnerships. Merck Canada continues to be at the forefront of research to prevent and treat diseases such as cancer, HIV, and Ebola. The company aspires to be the premier research-intensive biopharmaceutical company in the world. Marwan Akar has been the CEO of the company since 1997. | Drugstore Chains | Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree | |
B·R·A·H·M·S GmbH
 B·R·A·H·M·S GmbH Miscellaneous Commercial ServicesCommercial Services B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Cezanne SAS
 Cezanne SAS Pharmaceuticals: MajorHealth Technology Cezanne SAS develops and manufactures medical diagnostic systems, instrumentation, and reagents. The company was founded on June 23, 2000 and is headquartered in Nimes, France. | Pharmaceuticals: Major | Chairman | |
Inel SAS
 Inel SAS Medical SpecialtiesHealth Technology Inel SAS designs and manufactures x-ray diffraction system. It offers its solution for research and routine analytical applications. Its products are sold under the brand names of EQUINOX 100, EQUINOX 5000, SWAXS System, Nomadic stress system and Xsolo. The company was founded in 1974 by Michel Hugnot and is headquartered in Artenay, France. | Medical Specialties | Chief Executive Officer | |
ADAP Advocacy Association
 ADAP Advocacy Association Miscellaneous Commercial ServicesCommercial Services ADAP Advocacy Association operates an organization that promotes and enhances AIDS drug assistance programs. The non-profit company is based in Washington. | Miscellaneous Commercial Services | Director/Board Member | |
Oxoid International Ltd.
 Oxoid International Ltd. Medical DistributorsDistribution Services Part of Thermo Fisher Scientific, Inc., Oxoid International Ltd. is a holding British company that offers diagnostic products to microbiology laboratories. The company is based in Altrincham, UK. | Medical Distributors | Director/Board Member | |
| FLERIE INVEST AB | Pharmaceuticals: Major | Chief Operating Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
InDex Diagnostics AB
 InDex Diagnostics AB Pharmaceuticals: MajorHealth Technology Part of InDex Pharmaceuticals Holding AB, InDex Diagnostics AB manufactures pharmaceutical products. The company is based in Solna, Sweden. Peter Hakim Zerhouni has been the CEO of the Swedish company since 2015. | Pharmaceuticals: Major | Director/Board Member | |
InDex Pharmaceuticals AB
 InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Operating Officer | |
Innovativa Mindre Life Science
 Innovativa Mindre Life Science Miscellaneous Commercial ServicesCommercial Services Innovativa Mindre Life Science is an association of small and medium-sized Swedish companies that conduct research in the field of pharmaceuticals and medical technology. | Miscellaneous Commercial Services | Director/Board Member | |
| Concordia University | College/University | Masters Business Admin | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Chief Executive Officer | |
| FULLER, SMITH & TURNER P.L.C. | Restaurants | Comptroller/Controller/Auditor | |
Finastra Group Holdings Ltd.
 Finastra Group Holdings Ltd. Packaged SoftwareTechnology Services Finastra Group Holdings Ltd. engages in the provision of financial software solutions. The company was founded on March 29, 1978 and is headquartered in London, the United Kingdom. | Packaged Software | Director of Finance/CFO | |
| University of Abertay | College/University | Undergraduate Degree | |
| TELESTA THERAPEUTICS INC | Pharmaceuticals: Other | Director/Board Member | |
| THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Montréal | College/University | Undergraduate Degree | |
| INCHCAPE PLC | Specialty Stores | Corporate Officer/Principal | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO | |
Simplexia AB
 Simplexia AB BiotechnologyHealth Technology Simplexia AB is a company based in Gothenburg, Sweden that aims to launch the first vaccine for the treatment and prevention of genital herpes. The Swedish company is driven by the goal to curtail and treat infection with herpes simplex virus (HSV), one of the world's most prevalent sexually transmitted diseases. The team at Simplexia is composed of experts in pharmaceutical development, including Prof. Jan-Åke Liljeqvist and the Department of Virology at the Sahlgrenska Academy. The vaccine is based on research that showed glycoproteins from HSV-1 and 2, when administered as a vaccine, are highly immunogenic and provide protection in mouse models. | Biotechnology | Chairman | |
| Alceco International S.A. | Director/Board Member | ||
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| KABI-AM | Broadcasting | Corporate Officer/Principal | |
| DICOT PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
| Karolinska Institutet | College/University | Director/Board Member | |
| Qdoxx Pharma AB | Chairman | ||
| GlucoGene Pharma AB | Chairman | ||
| Oasmia SA | Chief Executive Officer |
Estadísticas
Internacional
| Suecia | 21 |
| Reino Unido | 11 |
| Canadá | 10 |
| Estados Unidos | 7 |
| Francia | 3 |
Sectorial
| Health Technology | 23 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Finance | 3 |
| Retail Trade | 3 |
Operativa
| Director/Board Member | 134 |
| Corporate Officer/Principal | 54 |
| Chairman | 43 |
| Independent Dir/Board Member | 40 |
| Chief Executive Officer | 28 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Paul Maier | 25 |
| Alastair Riddell | 24 |
| Richard Kimel | 22 |
| Karl Blom | 22 |
| Anders Waas | 21 |
| Melanie Lee | 19 |
| William Rucker | 18 |
| Lena Birgitta Degling Wikingsson | 16 |
| Per-Göran Gillberg | 11 |
| Michael Wolfe | 10 |
| Julian Aleksov | 10 |
| Per Wester | 10 |
| Lyne Fortin | 9 |
| Margareth Jorvid | 9 |
| Pernilla Sandwall | 8 |
- Bolsa de valores
- Insiders
- Carol Routledge
- Conexiones Empresas
